| Comparison of the binding of the gastrin-releasing peptide receptor (GRP-R) antagonist 68Ga-RM2 and 18F-FDG in breast cancer samples C Morgat, R Schollhammer, G Macgrogan, N Barthe, V Vélasco, D Vimont, ... PloS one 14 (1), e0210905, 2019 | 30 | 2019 |
| Silicon-Containing Neurotensin Analogues as Radiopharmaceuticals for NTS1-Positive Tumors Imaging R Fanelli, A Chastel, S Previti, E Hindié, D Vimont, P Zanotti-Fregonara, ... Bioconjugate Chemistry 31 (10), 2339-2349, 2020 | 25* | 2020 |
| Comparison of the radiolabeled PSMA-inhibitor 111In-PSMA-617 and the radiolabeled GRP-R antagonist 111In-RM2 in primary prostate cancer samples R Schollhammer, H De Clermont Gallerande, M Yacoub, ... EJNMMI research 9, 1-7, 2019 | 24 | 2019 |
| 18F-FDG PET/CT imaging of popliteal vasculitis associated with polyarteritis nodosa R Schollhammer, P Schwartz, ML Jullie, A Pham-Ledard, P Mercie, ... Clinical Nuclear Medicine 42 (8), e385-e387, 2017 | 18 | 2017 |
| Neurotensin receptor-1 expression in human prostate cancer: A pilot study on primary tumors and lymph node metastases C Morgat, A Chastel, V Molinie, R Schollhammer, G Macgrogan, ... International Journal of Molecular Sciences 20 (7), 1721, 2019 | 15 | 2019 |
| Comparison of 68Ga-PSMA-617 PET/CT and 68Ga-RM2 PET/CT in patients with localized prostate cancer who are candidates for radical prostatectomy: A prospective, single-arm … R Schollhammer, G Robert, J Asselineau, M Yacoub, D Vimont, ... Journal of Nuclear Medicine 64 (3), 379-385, 2023 | 10 | 2023 |
| 68Ga-PSMA-617 compared with 68Ga-RM2 and 18F-FCholine PET/CT for the initial staging of high-risk prostate cancer R Schollhammer, H de Clermont Gallerande, G Robert, M Yacoub, ... Clinical Nuclear Medicine 44 (9), e535-e536, 2019 | 10 | 2019 |
| In vitro and pilot in vivo imaging of 18 kDa translocator protein (TSPO) in inflammatory vascular disease R Schollhammer, S Lepreux, N Barthe, D Vimont, A Rullier, I Sibon, ... EJNMMI research 11 (1), 45, 2021 | 9 | 2021 |
| Theranostics of primary prostate cancer: Beyond PSMA and GRP-R R Schollhammer, ML Quintyn Ranty, H de Clermont Gallerande, ... Cancers 15 (8), 2345, 2023 | 5 | 2023 |
| Successful management of anti-mGluR1 encephalitis with immunosuppressive treatment: dengue virus as a trigger H Chaumont, A Petit, T Mameri, R Schollhammer, J Honnorat, A Lannuzel Mov Disord Clin Pract 6 (8), 727-8, 2019 | 5 | 2019 |
| Lymphatic drainage abnormalities in a child presenting as an unilateral vulvar swelling: a case of'Bicyclist's vulva'. O Ducharme, R Schollhammer, J Leduc, E Baubion, K Farid, E Amazan Journal of the European Academy of Dermatology & Venereology 34 (4), 2020 | 2 | 2020 |
| Imaging of a Pelvic Textiloma Using 18F-FDG PET/CT in a Patient With a History of Prostate Cancer: A Case Report and Review of the Literature R Schollhammer, H De Clermont-Gallerande, P Fernandez, M Meyer Clinical genitourinary cancer 15 (5), e859-e861, 2017 | 1 | 2017 |
| Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in Tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode S Bodin, LC Peuker, E Jestin, ID Alves, V Velasco, I Ait-Arsa, ... Bioconjugate Chemistry 34 (11), 2014-2021, 2023 | | 2023 |
| Targeting the Gastrin-Releasing Peptide receptor (GRP-R) for oncology imaging and therapy R Schollhammer Bordeaux, 2022 | | 2022 |
| Comparison of [68Ga] Ga-PSMA-617 PET/CT and [68Ga] Ga-RM2 PET/CT in patients with localized prostate cancer candidate for radical prostatectomy: a prospective, single arm … R Schollhammer, G Robert, J Asselineau, M Yacoub, D Vimont, ... Journal of Nuclear Medicine 63 (supplement 2), 2619-2619, 2022 | | 2022 |
| 18F-FDG PET/CT follow-up of urothelial bladder carcinoma treated with BCG-therapy: A rare case of BCGitis Q Ceyrat, A Barret, R Schollhammer Médecine Nucléaire 45 (5-6), 286-288, 2021 | | 2021 |
| Prospective comparison of 68Ga-RM2 PET/CT and 68Ga-PSMA-617 PET/CT for initial staging of prostate cancer. R Schollhammer, H De Clermont-Gallerande, G Robert, M Yacoub, ... Journal of Clinical Oncology 38 (6_suppl), 21-21, 2020 | | 2020 |
| Impact of late PET/CT imaging with Ga-68-RM2 in the characterization of prostate cancer R Schollhammer, H Gallerande, D Clermont, G Robert, M Yacoub, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | | 2019 |
| Prospective comparison of Ga-68-RM2 PET/CT and Ga-68-PSMA-617 PET/CT for initial staging of prostate cancer R Schollhammer, H Gallerande, D Clermont, G Robert, M Yacoub, ... EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING 46 (SUPPL 1 …, 2019 | | 2019 |
| Comparison of the radiolabeled PSMA-inhibitor. sup. 111In-PSMA-617 and the radiolabeled GRP-R antagonist. sup. 111In-RM2 in primary prostate cancer samples. R Schollhammer, HDC Gallerande, M Yacoub, MLQ Ranty, N Barthe, ... EJNMMI Research 9 (1), NA-NA, 2019 | | 2019 |
